• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞内环磷酸腺苷水平的升高会抑制胰腺腺癌细胞系中的表皮生长因子信号转导途径和细胞生长。

Elevation of intracellular cyclic adenosine monophosphate inhibits the epidermal growth factor signal transduction pathway and cellular growth in pancreatic adenocarcinoma cell lines.

作者信息

Lieberman M D, Paty P, Li X K, Naama H, Evoy D, Daly J M

机构信息

Department of Surgery, Cornell University Medical College-New York Hospital, NY., USA.

出版信息

Surgery. 1996 Aug;120(2):354-9. doi: 10.1016/s0039-6060(96)80309-6.

DOI:10.1016/s0039-6060(96)80309-6
PMID:8751604
Abstract

BACKGROUND

The epidermal growth factor (EGF) signal transduction pathway, frequently activated in pancreatic cancer, is an important regulator of cellular growth and transformation. This study examined whether activation of the cyclic adenosine monophosphate protein kinase A pathway may inhibit the EGF signal transduction pathway in pancreatic cancer cell lines.

METHODS

Human pancreatic cancer lines BxPC-3 and AsPC-1 were stimulated with EGF, forskolin, or both. Forskolin is a compound that increases cyclic adenosine monophosphate levels. Assays of cell lines were then obtained for cellular growth (MTT assay), anchorage-independent growth (soft agar), and EGF-induced mitogen-activated protein kinase activation as measured by an in-gel kinase assay.

RESULTS

Treatment with forskolin resulted in inhibition of EGF-induced activation of mitogen-activated protein kinase activity (BxPC-3 78% inhibition and AsPC-1 70% inhibition, p < 0.005), diminished cellular proliferation (BxPC-3 92% inhibition and AsPC-1 86% inhibition, p < 0.001), and formation of colonies in soft agar (BxPC-3 98% inhibition and AsPC-1 76% inhibition, p < 0.001). Forskolin did not inhibit EGF receptor autophosphorylation or tyrosine kinase signaling in response to EGF.

CONCLUSIONS

Forskolin-induced inhibition of mitogen-activated protein kinase is associated with diminished pancreatic cancer cell proliferation in vitro. Use of strategies to increase cyclic adenosine monophosphate levels may have therapeutic application in pancreatic cancer.

摘要

背景

表皮生长因子(EGF)信号转导通路在胰腺癌中经常被激活,是细胞生长和转化的重要调节因子。本研究检测了环磷酸腺苷蛋白激酶A通路的激活是否可能抑制胰腺癌细胞系中的EGF信号转导通路。

方法

用人胰腺癌系BxPC-3和AsPC-1分别用EGF、福斯高林或两者同时刺激。福斯高林是一种能增加环磷酸腺苷水平的化合物。然后对细胞系进行细胞生长(MTT法)、非锚定依赖性生长(软琼脂法)以及通过凝胶内激酶测定法测量的EGF诱导的丝裂原活化蛋白激酶激活的检测。

结果

用福斯高林处理导致EGF诱导的丝裂原活化蛋白激酶活性受到抑制(BxPC-3抑制78%,AsPC-1抑制70%,p<0.005),细胞增殖减少(BxPC-3抑制92%,AsPC-1抑制86%,p<0.001),以及在软琼脂中形成集落减少(BxPC-3抑制98%,AsPC-1抑制76%,p<0.001)。福斯高林不抑制EGF受体的自身磷酸化或对EGF的酪氨酸激酶信号传导。

结论

福斯高林诱导的丝裂原活化蛋白激酶抑制与体外胰腺癌增殖减少有关。采用提高环磷酸腺苷水平的策略可能在胰腺癌治疗中具有应用价值。

相似文献

1
Elevation of intracellular cyclic adenosine monophosphate inhibits the epidermal growth factor signal transduction pathway and cellular growth in pancreatic adenocarcinoma cell lines.细胞内环磷酸腺苷水平的升高会抑制胰腺腺癌细胞系中的表皮生长因子信号转导途径和细胞生长。
Surgery. 1996 Aug;120(2):354-9. doi: 10.1016/s0039-6060(96)80309-6.
2
Growth factor-induced transcription via the serum response element is inhibited by cyclic adenosine 3',5'-monophosphate in MCF-7 breast cancer cells.在MCF-7乳腺癌细胞中,环磷酸腺苷抑制经由血清反应元件的生长因子诱导转录。
Endocrinology. 1997 Jun;138(6):2219-26. doi: 10.1210/endo.138.6.5159.
3
Parietal cell MAP kinases: multiple activation pathways.壁细胞丝裂原活化蛋白激酶:多种激活途径。
Am J Physiol. 1996 Oct;271(4 Pt 1):G640-9. doi: 10.1152/ajpgi.1996.271.4.G640.
4
Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines.表皮生长因子(EGF)受体阻断可抑制表皮生长因子、胰岛素样生长因子I以及蛋白激酶A激活剂对前列腺癌细胞系中丝裂原活化蛋白激酶途径的作用。
Cancer Res. 1999 Jan 1;59(1):227-33.
5
Beta-adrenergic receptor activation inhibits keratinocyte migration via a cyclic adenosine monophosphate-independent mechanism.β-肾上腺素能受体激活通过一种不依赖环磷酸腺苷的机制抑制角质形成细胞迁移。
J Invest Dermatol. 2002 Dec;119(6):1261-8. doi: 10.1046/j.1523-1747.2002.19611.x.
6
Protein tyrosine phosphorylation induced by epidermal growth factor and insulin-like growth factor-I in a rat clonal dental pulp-cell line.表皮生长因子和胰岛素样生长因子-I在大鼠克隆牙髓细胞系中诱导的蛋白质酪氨酸磷酸化
Arch Oral Biol. 1995 Oct;40(10):921-9. doi: 10.1016/0003-9969(95)00061-s.
7
Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.葡萄籽提取物抑制表皮生长因子(EGF)诱导的和组成型激活的促有丝分裂信号传导,但激活人前列腺癌DU145细胞中的JNK:在抗增殖和凋亡中的可能作用。
Oncogene. 2003 Mar 6;22(9):1302-16. doi: 10.1038/sj.onc.1206265.
8
Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein alpha(I)-mediated activation of phosphotyrosine phosphatase.促黄体生成素释放激素通过G蛋白α(I)介导的磷酸酪氨酸磷酸酶激活在人子宫内膜和卵巢癌细胞中的抗增殖信号传导。
Endocrinology. 2001 Jun;142(6):2369-80. doi: 10.1210/endo.142.6.8190.
9
Elevation of intracellular cAMP inhibits growth factor-mediated matrix metalloproteinase-9 induction and keratinocyte migration.细胞内cAMP水平升高会抑制生长因子介导的基质金属蛋白酶-9的诱导以及角质形成细胞的迁移。
Mol Pharmacol. 2000 Jul;58(1):145-51. doi: 10.1124/mol.58.1.145.
10
Activation and glucagon regulation of mitogen-activated protein kinases (MAPK) by insulin and epidermal growth factor in cultured rat and human hepatocytes.胰岛素和表皮生长因子对培养的大鼠及人肝细胞中丝裂原活化蛋白激酶(MAPK)的激活作用及胰高血糖素调节
Cell Biochem Funct. 1998 Jun;16(2):77-85. doi: 10.1002/(SICI)1099-0844(199806)16:2<77::AID-CBF769>3.0.CO;2-U.

引用本文的文献

1
Role of the cyclic AMP response element binding complex and activation of mitogen-activated protein kinases in synergistic activation of the glycoprotein hormone alpha subunit gene by epidermal growth factor and forskolin.环磷酸腺苷反应元件结合复合物的作用以及丝裂原活化蛋白激酶的激活在表皮生长因子和福斯高林协同激活糖蛋白激素α亚基基因中的作用。
Mol Cell Biol. 2000 May;20(10):3331-44. doi: 10.1128/MCB.20.10.3331-3344.2000.